A detailed history of Raab & Moskowitz Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 1,786 shares of VRTX stock, worth $922,897. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,786
Previous 1,738 2.76%
Holding current value
$922,897
Previous $726,000 15.29%
% of portfolio
0.23%
Previous 0.2%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$392.81 - $485.53 $18,854 - $23,305
48 Added 2.76%
1,786 $837,000
Q4 2023

Feb 02, 2024

SELL
$343.0 - $410.68 $9,261 - $11,088
-27 Reduced 1.53%
1,738 $707,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $16,427 - $18,739
-58 Reduced 3.18%
1,765 $556,000
Q4 2022

Jan 27, 2023

BUY
$285.76 - $321.48 $35,720 - $40,185
125 Added 7.36%
1,823 $0
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $1,369 - $1,527
-5 Reduced 0.29%
1,698 $491,000
Q1 2022

May 10, 2022

BUY
$221.42 - $260.97 $11,071 - $13,048
50 Added 3.02%
1,703 $444,000
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $3,105 - $3,619
15 Added 0.92%
1,653 $355,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $1,242 - $1,656
-6 Reduced 0.36%
1,638 $387,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $1,022 - $1,212
4 Added 0.24%
1,644 $447,000
Q2 2020

Aug 13, 2020

SELL
$225.48 - $295.8 $6,313 - $8,282
-28 Reduced 1.68%
1,640 $476,000
Q1 2018

Apr 25, 2018

BUY
$151.6 - $177.13 $252,868 - $295,452
1,668 New
1,668 $271,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Raab & Moskowitz Asset Management LLC Portfolio

Follow Raab & Moskowitz Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.